Moderna Share is an American Biotech company that is primarily into drug development and production. The company uses messenger RNA (mRNA) for developing vaccines. The idea is to alter the system of the body to create antibodies and vaccines instead of developing a vaccine outside the body and then injecting it. Major companies have dropped this method due to the failure of the technique in producing drugs. The potential drugs developed usually have a lot of side effects, which leads to its failure. Even then, the company only focusses on this method. As of 2020, it has not produced a single mRNA drug. The company is very secretive and does not publish its work.
Coronavirus Vaccine Development By Moderna
Moderna is one of the leading companies in the race of developing a vaccine for the much-needed coronavirus. It was one of the first companies to start human trials for the vaccine. They initially said that the vaccine helped the body produce antibodies to fight coronavirus and declared the first human trials as a success.
Doubts In Vaccine By Moderna
The worst thing happened for Moderna, which everyone had feared. The potential vaccine started to show side effects in the body of people on whom the trials done. A volunteer for the vaccine said that he started feeling cold after he reached home after his second dose. He even felt nauseated, and his muscles hurt as a part of the side effect. These statements have caused serious doubts about the vaccine that is being developed by Moderna.
Fluctuation In The Shares Of Moderna
Shares of Moderna soared high when news about the start of human trials made it to the headlines. All looked good for the company. The share price went higher when the company reported about the success of human trials. Moderna shares tumbled down when the headlines went against their favor. The share price fell drastically when reports came out, suggesting the side effects of the vaccine.